Cohen: Supreme Court decision a ‘strong blow to the abortion restriction agenda’

Harvard Law School Professor I. Glenn Cohen, faculty director of the School’s Petrie-Flom Center for Health Law Policy, Biotechnology & Bioethics spoke with the Harvard Gazette about Monday’s ruling by the Supreme Court that overturned a Texas law requiring that abortion clinics maintain hospital-like standards at their facilities as well as admitting privileges at local hospitals.

Faculty Books In Brief—Spring 2016

“FDA in the 21st Century: The Challenges of Regulating Drugs and New Technologies,” edited by Holly Fernandez Lynch and I. Glenn Cohen ’03 (Columbia). Stemming from a 2013 conference at HLS, the book features essays covering major developments that have changed how the FDA regulates; how the agency encourages transparency; First Amendment issues; access to drugs; and evolving issues in drug-safety communication. These issues, the editors write, lie “at the heart of our health and health care.”

Harvard Law School launches the Campaign for the Third Century

With a nod to its historic past and a look ahead to its future, Harvard Law School has formally launched the Campaign for the Third Century, which seeks to raise $305 million in support of students and faculty, clinical education, new and innovative research, and the continued enhancement of the Law School campus.

Emerging mobile health technologies need FDA oversight

Smart phones and other mobile devices have the potential to transform healthcare, improving medical outcomes, reducing errors, and broadening access to healthcare. The Food and Drug Administration must continue to have jurisdiction over these “mobile health” or “mHealth” innovations to address emerging risks, according to I. Glenn Cohen, Nathan G. Cortez, and Aaron S. Kesselheim, […]